Royal Adelaide Hospital
Adelaide, Australia
NCT Number: NCT05026632
This study will examine the safety and efficacy NPI-002 intravitreal implants post vitrectomy.
This study is active but is not currently recruiting participants.
Notify Me18 year and older
All sexes
Interventional
Phase 1 / Phase 2
Adelaide, Australia
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Implant inserted during vitrectomy.
Time frame: 6 months
Change from Baseline
This study is active but is not currently recruiting participants.
Notify MeNacuity Pharmaceuticals, Inc.
Industry
Safety and Efficacy of NPI-002 Intravitreal Implant for the Delay of Cataract Progression in Patients Undergoing Vitrectomy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05161520
Cataract, Eye Diseases
Guangzhou, Guangdong, China
View Trial DetailsNCT00594672
Age-Related Macular Degeneration, Cataract
Bethesda, Maryland, United States
View Trial DetailsNCT05317728
Cataract, Eye Diseases
San José, Costa Rica
View Trial DetailsNCT07741370
Age-related Cataract, Capsule Opacification
Hangzhou, Zhejiang, China
View Trial Details